What does CUSIP 62957M104 represent in this 13F holders report?

CUSIP 62957M104 is the security identifier for NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR used to aggregate holder disclosures.

How many institutions held NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR in Q4 2017?

No institutional holders were reported for NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR in Q4 2017; review adjacent reporting periods for trend context.

NABRIVA THERAPEUTICS AG - SPONSORED ADR (NBRV)

CUSIP: 62957M104

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Equity / SPONSORED ADR
Total 13F shares: 0
Share change: -86,710
Total reported value: $0
Number of holders: 0
Value change: -$710,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 62957M104?
CUSIP 62957M104 identifies NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2017

Recent filing periods for CUSIP 62957M104:

Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016

NABRIVA THERAPEUTICS AG - SPONSORED ADR (NBRV)

Q4 2017 13F Holders as of 31 Dec 2017

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR as of Q4 2017.